通过p53调节通过级纳米催化药物进行内源性亡放大
Tan Wu1, Xiaoyue Xu1, Dan Xu2
1Department of Anesthesiology and Perioperative medicine, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center For Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, School of Medicine, Shanghai Fourth People's Hospital, Tongji University, Shanghai, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|February 11, 2026
概括
这项研究引入了一种新的纳米催化疗法,使用工程金属有机框架纳米医学 (MAL) 来放大癌细胞亡. MAL有效触发DNA损伤和细胞循环中断,抑制瘤生长,具有良好的生物相容性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 纳米催化疗法通过将基质转化为细胞毒剂提供局部癌症治疗.
- 目前的局限性包括缺乏持久的,针对DNA的细胞毒性机制.
- 增强的亡诱导对于有效杀死癌细胞至关重要.
研究的目的:
- 开发一个级联纳米催化剂策略,用于扩大癌细胞内源性亡.
- 为此目的设计一个金属有机框架纳米药物 (MOF-Au-L-阿,MAL).
- 调查MAL的作用机制和体内疗效.
主要方法:
- 制造MOF-Au-L-氨酸纳米药物 (MAL). . 的制造.
- 在实验室分析反应性氧物种的产生,DNA损伤,细胞循环停止和细胞亡.
- 全基因组RNA测序以确定通路激活 (例如,p53).
- 在体内研究,以评估瘤抑制和生物相容性.
主要成果:
- MAL有效催化基和超氧化离子的生成,导致过氧酸盐的形成.
- 过氧酸盐会引发显著的DNA损伤,损害DNA修复,并破坏细胞循环.
- 马尔激活p53通路,并通过BAX/Bcl-2/caspase-3轴促进线粒体介导的亡.
- 在体内研究表明,有效抑制瘤生长,具有良好的生物相容性.
结论:
- 开发的级联纳米催化剂策略有效地放大了癌症治疗的内源性亡.
- MAL显示出作为下一代纳米催化治疗剂的潜力,具有增强的疗效和降低的毒性.
- 进一步研究MAL的治疗应用是有必要的.
相关概念视频
01:23Negative Regulator Molecules
38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
01:24Intracellular Signaling Cascades
53.7K
Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
53.7K
02:04Covalently Linked Protein Regulators
9.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
9.7K
01:25Rab Cascades
3.6K
Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
3.6K
01:30Apoptosis
15.3K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
15.3K
01:22Amplifying Signals via Enzymatic Cascade
18.6K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.6K